Kaira, Kyoichi <br/><br/>
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.  [electronic resource] 

 -  BMC cancer  Oct 2013 
 - 482 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-13-482  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Biliary Tract Neoplasms--drug therapy<br/>Biomarkers, Tumor--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Deoxycytidine--analogs & derivatives<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--pharmacology<br/>Fusion Regulatory Protein-1--metabolism<br/>Humans<br/>Kaplan-Meier Estimate<br/>Large Neutral Amino Acid-Transporter 1--metabolism<br/>Lymphatic Metastasis<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Multivariate Analysis<br/>Prognosis<br/>Retrospective Studies<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays<br/>Gemcitabine